Ushio Inc.
Industry
- Medical Devices
- Infection Control-Sterilization
- Diversified
See more in Biomedtracker
Latest on Ushio Inc.
In Vivo
• By Maureen Riordan and Amanda Micklus
Device Transactions Device financing during 2015's third quarter reached $1.4 billion, a 22% dip from Q2's $1.8 billion total. ( See Exhibit 1. ) Late-stage venture capital rounds represented most of
Scrip
IN VITRO DIAGNOSTICS Interleukin Genetics Inc. New York University New York University School of Medicine Interleukin Genetics, NYU School of Medicine to develop genetic test for OA Interleukin Ge
Medtech Insight
Patient safety concerns and limited payments for hospital-acquired conditions (HACs) are fueling growth in new, point-of-care (POC) imaging devices designed to simplify and facilitate placement of per